Piper Sandler Reiterates Overweight Rating on Pacira Pharmaceuticals (PCRX)

Go back to Piper Sandler Reiterates Overweight Rating on Pacira Pharmaceuticals (PCRX)
PACIRA (NASDAQ: PCRX) Delayed: 26.46 +0.05 (0.19%)
Previous Close $26.41    52 Week High $80.25 
Open $26.09    52 Week Low $30.25 
Day High $26.68    P/E N/A 
Day Low $25.92    EPS $-2.08 
Volume 688,473